Single-cell multi-omics analysis reveals IFN-driven alterations in T lymphocytes and natural killer cells in systemic lupus erythematosus
Open Access
- 14 June 2021
- journal article
- Published by F1000 Research Ltd in Wellcome Open Research
Abstract
Background: The characterisation of the peripheral immune system in the autoimmune disease systemic lupus erythematosus (SLE) at the single-cell level has been limited by the reduced sensitivity of current whole-transcriptomic technologies. Here we employ a targeted single-cell multi-omics approach, combining protein and mRNA quantification, to generate a high-resolution map of the T lymphocyte and natural killer (NK) cell populations in blood from SLE patients. Methods: We designed a custom panel to quantify the transcription of 534 genes in parallel with the expression of 51 surface protein targets using the BD Rhapsody AbSeq single-cell system. We applied this technology to profile 20,656 T and NK cells isolated from peripheral blood from an SLE patient with a type I interferon (IFN)-induced gene expression signature (IFNhi), and an age- and sex- matched IFNlow SLE patient and healthy donor. Results: We confirmed the presence of a rare cytotoxic CD4+ T cell (CTL) subset, which was exclusively present in the IFNhi patient. Furthermore, we identified additional alterations consistent with increased immune activation in this patient, most notably a shift towards terminally differentiated CD57+ CD8+ T cell and CD16+ NKdim phenotypes, and the presence of a subset of recently-activated naïve CD4+ T cells. Conclusions: Our results identify IFN-driven changes in the composition and phenotype of T and NK cells that are consistent with a systemic immune activation within the IFNhi patient, and underscore the added resolving power of this multi-omics approach to identify rare immune subsets. Consequently, we were able to find evidence for novel cellular peripheral biomarkers of SLE disease activity, including a subpopulation of CD57+ CD4+ CTLs.Keywords
Funding Information
- Juvenile Diabetes Research Foundation United States of America (1-SRA-2019-657-A-N, 4-SRA-2017-473-A-A)
- Wellcome Trust (107212)
This publication has 27 references indexed in Scilit:
- Functional Significance of CD57 Expression on Human NK Cells and Relevance to DiseaseFrontiers in Immunology, 2013
- IFNα and its response proteins, IP-10 and SIGLEC-1, are biomarkers of disease activity in systemic lupus erythematosusAnnals Of The Rheumatic Diseases, 2012
- Type I IFN system in the development and manifestations of SLECurrent Opinion in Rheumatology, 2012
- Systemic Lupus ErythematosusThe New England Journal of Medicine, 2011
- Phenotype and function of natural killer cells in systemic lupus erythematosus: Excess interferon-γ production in patients with active diseaseArthritis & Rheumatism, 2011
- Type I Interferon in Systemic Lupus Erythematosus and Other Autoimmune DiseasesImmunity, 2006
- Development of Autoantibodies before the Clinical Onset of Systemic Lupus ErythematosusThe New England Journal of Medicine, 2003
- Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus BloodThe Journal of Experimental Medicine, 2003
- Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupusProceedings of the National Academy of Sciences of the United States of America, 2003
- Characterization of CD4+ CTLs Ex VivoThe Journal of Immunology, 2002